Published in Drugs Aging on July 01, 2015
The potential role of neuropathic mechanisms in dry eye syndromes. J Optom (2016) 0.75
A clinical utility assessment of the automatic measurement method of the quality of Meibomian glands. Biomed Eng Online (2017) 0.75
A novel TRPM8 agonist relieves dry eye discomfort. BMC Ophthalmol (2017) 0.75
Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol (2017) 0.75
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf (2007) 11.76
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) (1987) 4.54
Prevalence of dry eye syndrome among US women. Am J Ophthalmol (2003) 4.46
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci (2001) 3.72
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology (2000) 2.74
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol (2009) 2.65
Hormone replacement therapy and dry eye syndrome. JAMA (2001) 2.46
Acupuncture for treating dry eye: a randomized placebo-controlled trial. Acta Ophthalmol (2010) 2.25
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol (2010) 1.95
Dry eye as a mucosal autoimmune disease. Int Rev Immunol (2013) 1.85
The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol (2005) 1.74
Incidence of dry eye in an older population. Arch Ophthalmol (2004) 1.74
Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol (2004) 1.70
The diagnosis and management of dry eye: a twenty-five-year review. Cornea (2000) 1.67
Acupuncture--from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses (1995) 1.60
Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol (2012) 1.53
Sensory neurons, ion channels, inflammation and the onset of neuropathic pain. Can J Neurol Sci (2012) 1.45
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol (2004) 1.39
Controlled study of the use of autologous serum in dry eye patients. Cornea (2001) 1.39
Age-related differences in the normal human cornea: a laser scanning in vivo confocal microscopy study. Br J Ophthalmol (2007) 1.33
The effect of age on the corneal subbasal nerve plexus. Cornea (2005) 1.22
Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Cornea (2004) 1.22
The contribution of meibomian disease to dry eye. Ocul Surf (2004) 1.22
Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther (2008) 1.21
Functional brain connectivity using fMRI in aging and Alzheimer's disease. Neuropsychol Rev (2014) 1.20
Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology (1995) 1.19
A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol (2011) 1.11
Effects of age and dysfunction on human meibomian glands. Arch Ophthalmol (2011) 1.11
Evaluation of the clinical course of dry eye syndrome. Arch Ophthalmol (2003) 1.11
Age-related changes in the meibomian gland. Exp Eye Res (2009) 1.10
Evaluation of dry eye. Surv Ophthalmol (2012) 1.10
A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging (2013) 1.07
Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea (2010) 1.07
Assessing the severity of conjunctivochalasis in a senile population: a community-based epidemiology study in Shanghai, China. BMC Public Health (2011) 1.05
Spontaneous eyeblink activity. Ocul Surf (2011) 1.04
Microneurographic assessment of C-fibre function in aged healthy subjects. J Physiol (2008) 1.04
Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res (2003) 1.02
Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol (2013) 1.02
Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea (2007) 1.02
Neuropathic ocular pain: an important yet underevaluated feature of dry eye. Eye (Lond) (2014) 1.00
Increasing prevalence and severity of conjunctivochalasis with aging detected by anterior segment optical coherence tomography. Am J Ophthalmol (2012) 1.00
Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea (2013) 0.99
Acupuncture for treating dry eye: a systematic review. Acta Ophthalmol (2011) 0.98
The casual level of meibomian lipids in humans. Curr Eye Res (1993) 0.98
Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Curr Eye Res (2012) 0.98
A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Am J Ophthalmol (2008) 0.98
Aging and dry eye disease. Exp Gerontol (2012) 0.97
Age-related modifications of corneal sensitivity. Ophthalmologica (2004) 0.97
A clinical study of acupuncture and SSP (silver spike point) electro-therapy for dry eye syndrome. Am J Chin Med (2006) 0.97
Topical cyclosporine 0.05% for the prevention of dry eye disease progression. J Ocul Pharmacol Ther (2010) 0.97
Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea (2010) 0.97
A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res (2012) 0.96
Age- and gender-related tear function changes in normal population. Eye (Lond) (2009) 0.96
Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. Br J Ophthalmol (2008) 0.96
Treatment of ocular inflammatory conditions with loteprednol etabonate. Br J Ophthalmol (2008) 0.95
MR imaging of the lacrimal gland. Age-related and gender-dependent changes in size and structure. Acta Radiol (1996) 0.94
Physical changes in human meibum with age as measured by infrared spectroscopy. Ophthalmic Res (2010) 0.94
Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction. Am J Ophthalmol (2012) 0.94
Alterations of tear neuromediators in dry eye disease. Arch Ophthalmol (2011) 0.92
The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca. Curr Med Res Opin (2005) 0.91
Cutaneous C-fiber nociceptor responses and nociceptive behaviors in aged Sprague-Dawley rats. Pain (2010) 0.91
The aging Meibomian gland: an in vivo confocal study. Invest Ophthalmol Vis Sci (2013) 0.89
Acupuncture treatment in patients with keratoconjunctivitis sicca: a pilot study. Acta Ophthalmol Scand (2004) 0.89
Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. Cornea (2010) 0.88
Pharmacological management of dry eye in the elderly patient. Drugs Aging (2008) 0.88
Age-related changes in morphology and secretory responses of male rat lacrimal gland. J Auton Nerv Syst (1998) 0.87
A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome. Br J Ophthalmol (2010) 0.87
Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial. Ophthalmology (2012) 0.87
Changes in human meibum lipid composition with age using nuclear magnetic resonance spectroscopy. Invest Ophthalmol Vis Sci (2012) 0.87
Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Clin Exp Optom (2010) 0.87
Evidence to suggest morphological and physiological alterations of lacrimal gland acini with ageing. Exp Eye Res (1999) 0.87
Evaluation of tear stability after surgery for conjunctivochalasis. Optom Vis Sci (2011) 0.86
Nerve growth factor therapy for corneal disease. Curr Opin Ophthalmol (2012) 0.86
Tear lipid layer structure and stability following expression of the meibomian glands. Ophthalmic Physiol Opt (1995) 0.86
Treatment of blepharitis: recent clinical trials. Ocul Surf (2014) 0.86
Current Approach to Dry Eye Disease. Clin Rev Allergy Immunol (2015) 0.85
Prevalence, risk factors, and morbidity of eye lid laxity in a veteran population. Cornea (2015) 0.85
Effects of age on morphology, protein synthesis and secretagogue-evoked secretory responses in the rat lacrimal gland. Mol Cell Biochem (2003) 0.84
One man's poison is another man's meat: using azithromycin-induced phospholipidosis to promote ocular surface health. Toxicology (2014) 0.84
Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study. Eye (Lond) (2012) 0.84
Ocular surface disease and dacryoadenitis in aging C57BL/6 mice. Am J Pathol (2014) 0.84
Corneal Confocal Microscopy in Dry Eye Treated with Corticosteroids. Optom Vis Sci (2015) 0.84
The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefes Arch Clin Exp Ophthalmol (2014) 0.83
Interventions for chronic blepharitis. Cochrane Database Syst Rev (2012) 0.83
The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome. Int Ophthalmol (2014) 0.83
Clinical treatment of dry eye using 0.03% tacrolimus eye drops. Cornea (2012) 0.83
Neurologic evaluation of acute lacrimomimetic effect of cyclosporine in an experimental rabbit dry eye model. Invest Ophthalmol Vis Sci (2009) 0.83
Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. Clin Ophthalmol (2013) 0.83
Influence of age, gender and iris color on mechanical and chemical sensitivity of the cornea and conjunctiva. Exp Eye Res (2006) 0.83
Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2015) 0.83
Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops. J Ocul Pharmacol Ther (2013) 0.82
Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis. Korean J Ophthalmol (2012) 0.82
Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors. Exp Neurol (2014) 0.82
Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Cornea (2014) 0.81
Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol (2014) 0.81
Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study. Korean J Ophthalmol (2011) 0.81
Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study. J Fr Ophtalmol (2014) 0.81
Morphological evaluation of meibomian glands using noncontact infrared meibography. Ocul Surf (2012) 0.81
Evaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunction. Clin Ophthalmol (2014) 0.80
Evaluation of age-related changes in human palpebral conjunctiva and meibomian glands by in vivo confocal microscopy. Cornea (2011) 0.80
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum (2006) 2.26
Comparison of IOL power calculation methods and intraoperative wavefront aberrometer in eyes after refractive surgery. J Refract Surg (2013) 2.10
The diagnostic utility of anterior chamber paracentesis with polymerase chain reaction in anterior uveitis. Am J Ophthalmol (2013) 2.08
Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology (2010) 1.97
Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology (2008) 1.63
Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol (2012) 1.53
Anterior chamber angiostrongyliasis. JAMA Ophthalmol (2013) 1.39
Epidemiology and visual outcomes in patients with infectious scleritis. Cornea (2013) 1.15
Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology (2011) 1.13
Validation of a photographic vitreous haze grading technique for clinical trials in uveitis. Am J Ophthalmol (2011) 1.08
Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001 to 2010. Ophthalmology (2012) 1.07
Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Br J Ophthalmol (2006) 1.05
Exfoliation syndrome: new genetic and pathophysiologic insights. Curr Opin Ophthalmol (2013) 1.01
Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium. Ophthalmology (2012) 0.99
Current Thoughts in Fungal Keratitis: Diagnosis and Treatment. Curr Fungal Infect Rep (2013) 0.99
In vivo morphologic characteristics of Salzmann nodular degeneration with ultra-high-resolution optical coherence tomography. Am J Ophthalmol (2010) 0.95
Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection. Transplantation (2008) 0.94
Dry eye syndrome, posttraumatic stress disorder, and depression in an older male veteran population. Invest Ophthalmol Vis Sci (2013) 0.90
Subconjunctival masses associated with central nervous system rosai-dorfman disease. Cornea (2011) 0.90
Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol (2013) 0.89
Increased mortality risk among the visually impaired: the roles of mental well-being and preventive care practices. Invest Ophthalmol Vis Sci (2012) 0.88
Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study. Ocul Immunol Inflamm (2010) 0.86
Prevalence, risk factors, and morbidity of eye lid laxity in a veteran population. Cornea (2015) 0.85
Corneal Melt While Using Topical Bevacizumab Eye Drops. Ophthalmic Surg Lasers Imaging (2010) 0.84
Refractive outcomes of combined cataract and glaucoma surgery. J Glaucoma (2015) 0.84
Racial disparities in quality-adjusted life-years associated with diabetes and visual impairment. Diabetes Care (2012) 0.82
Comparison of two methods for composite score generation in dry eye syndrome. Invest Ophthalmol Vis Sci (2013) 0.79
Femtosecond-assisted anterior lamellar corneal staining-tattooing in a blind eye with leukocoria. Cornea (2009) 0.78
Impact of Eyelid Laxity on Symptoms and Signs of Dry Eye Disease. Cornea (2016) 0.78
Epithelial ingrowth after LASIK: clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift. J Refract Surg (2012) 0.77
Superficial epithelial keratectomy, cautery, and amniotic membrane transplant for the treatment of painful bullous keratopathy in eyes with poor visual potential. Cornea (2014) 0.77
Epidemiology of Ocular Surface Squamous Neoplasia in a Veterans Affairs Population. Cornea (2013) 0.77
Atypical presentation of Salzmann nodular degeneration diagnosed with ultra-high-resolution optical coherence tomography. Ophthalmic Surg Lasers Imaging (2011) 0.77
Rheumatic disease and scleritis. Ophthalmology (2007) 0.77
Epidemiology of Meibomian Gland Dysfunction in an Elderly Population. Cornea (2016) 0.77
Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium. Clin Ophthalmol (2013) 0.77
Recurrence rates of herpes simplex virus keratitis in contact lens and non-contact lens wearers. Eye Contact Lens (2009) 0.76
Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms. Eye Contact Lens (2016) 0.76
High-Resolution Optical Coherence Tomography in the Differentiation of Inflammatory Versus Noninflammatory Peripheral Corneal Thinning. Cornea (2017) 0.75
Ocular Inflammation in the Setting of Concomitant Systemic Autoimmune Conditions in an Older Male Population. Cornea (2015) 0.75
Reply: To PMID 23415597. Am J Ophthalmol (2013) 0.75
Reply: To PMID 23820231. J Refract Surg (2013) 0.75
Compliance and Subjective Patient Responses to Eyelid Hygiene. Eye Contact Lens (2016) 0.75
Cataract Surgery After Refractive Surgery. Int Ophthalmol Clin (2016) 0.75
Ocular surface symptoms in veterans returning from operation Iraqi freedom and operation enduring freedom. Invest Ophthalmol Vis Sci (2014) 0.75
High-Resolution Optical Coherence Tomography Findings of Lisch Epithelial Corneal Dystrophy. Cornea (2016) 0.75
Endothelial graft failure after contralateral autologous corneal transplantation. Cornea (2013) 0.75
Long-term effects of cataract surgery on tear film parameters. ScientificWorldJournal (2013) 0.75
Sub-basal Corneal Nerve Plexus Analysis Using a New Software Technology. Eye Contact Lens (2017) 0.75
Application of Scanning Electron Microscopy With Energy-Dispersive X-Ray Spectroscopy for Analyzing Ocular Surface Particles on Schirmer Strips. Cornea (2017) 0.75
Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia. Cornea (2017) 0.75
Neuropathic-Like Ocular Pain and Nonocular Comorbidities Correlate With Dry Eye Symptoms. Eye Contact Lens (2017) 0.75
Surgical and refractive outcomes of cataract surgery with toric intraocular lens implantation at a resident-teaching institution. J Cataract Refract Surg (2011) 0.75
Epipremnum aureum Keratopathy: Case Report and Review of the Literature. Eye Contact Lens (2020) 0.75
Agreement between Pentacam and IOL master in patients undergoing toric IOL implantation. J Refract Surg (2013) 0.75
Refractive surgical problem: September consultation. J Cataract Refract Surg (2012) 0.75
Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders. Eye Contact Lens (2017) 0.75
Brimonidine allergy presenting as vernal-like keratoconjunctivitis. J Glaucoma (2015) 0.75
Treatment of Refractory Filamentary Keratitis With Autologous Serum Tears. Eye Contact Lens (2017) 0.75
Delayed expulsive choroidal hemorrhage after penetrating keratoplasty. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
Neuropathic symptoms of the ocular surface: dryness, pain, and itch. Curr Opin Allergy Clin Immunol (2017) 0.75
Updates in Ocular Surface Tumor Diagnostics. Int Ophthalmol Clin (2017) 0.75
Long-term Outcomes of Flap Amputation After LASIK. J Refract Surg (2016) 0.75
C-reactive protein levels and tear function parameters. Ophthalmology (2013) 0.75
Surgical Simulation Training Reduces Intraoperative Cataract Surgery Complications Among Residents. Simul Healthc (2017) 0.75